164 related articles for article (PubMed ID: 33427515)
1. Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α.
Qi Y; Liu G
Drug Deliv; 2021 Dec; 28(1):171-182. PubMed ID: 33427515
[TBL] [Abstract][Full Text] [Related]
2. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
[TBL] [Abstract][Full Text] [Related]
4. [The synergistic antitumor effects of berberine alpha-hydroxy-beta-decanoylethyl sulfonate with hydroxycamptothecine and its effect on topoisomerase].
Lin J; Wang X
Yao Xue Xue Bao; 2011 Apr; 46(4):390-4. PubMed ID: 21751491
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyethyl starch-10-hydroxy camptothecin conjugate: synthesis, pharmacokinetics, cytotoxicity and pharmacodynamics research.
Li G; Cai C; Qi Y; Tang X
Drug Deliv; 2016; 23(1):277-84. PubMed ID: 24833272
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
[TBL] [Abstract][Full Text] [Related]
7. Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity.
Cai J; Luo S; Lv X; Deng Y; Huang H; Zhao B; Zhang Q; Li G
Int J Pharm; 2019 Nov; 571():118693. PubMed ID: 31525442
[TBL] [Abstract][Full Text] [Related]
8. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.
Pu X; Zhao L; Li J; Song R; Wang Y; Yu K; Hou X; Qiao P; Zong L; Chang S
Acta Biomater; 2019 Apr; 88():357-369. PubMed ID: 30822554
[TBL] [Abstract][Full Text] [Related]
9. Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis.
Wang Y; Wang H; Zhang W; Shao C; Xu P; Shi CH; Shi JG; Li YM; Fu Q; Xue W; Lei YH; Gao JY; Wang JY; Gao XP; Li JQ; Yuan JL; Zhang YT
PLoS One; 2013; 8(1):e50175. PubMed ID: 23365634
[TBL] [Abstract][Full Text] [Related]
10. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
[TBL] [Abstract][Full Text] [Related]
11. Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer.
Li G; Zhao M; Zhao L
Drug Deliv; 2020 Dec; 27(1):519-529. PubMed ID: 32228107
[TBL] [Abstract][Full Text] [Related]
12. [Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
Liang YJ; Fu LW; Ding Y; Xiong HY; Chen LM; Yang XP; Pan QC
Ai Zheng; 2003 Apr; 22(4):368-71. PubMed ID: 12703990
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of HCPT on expression of HIF-1alpha and downstream genes in hypoxic human cervical SiHa cancer cells.
Shi W; Yu S
J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):586-9. PubMed ID: 18060642
[TBL] [Abstract][Full Text] [Related]
14. Quercetin exerts synergetic anti-cancer activity with 10-hydroxy camptothecin.
Tang Q; Ji F; Wang J; Guo L; Li Y; Bao Y
Eur J Pharm Sci; 2017 Nov; 109():223-232. PubMed ID: 28822757
[TBL] [Abstract][Full Text] [Related]
15. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J
Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212
[TBL] [Abstract][Full Text] [Related]
16. Well-defined hydroxyethyl starch-10-hydroxy camptothecin super macromolecule conjugate: cytotoxicity, pharmacodynamics research, tissue distribution test and intravenous injection safety assessment.
Li G; Zhao M; Zhao L
Drug Deliv; 2016 Oct; 23(8):2860-2868. PubMed ID: 26836216
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
19. Tirapazamine sensitizes hepatocellular carcinoma cells to topoisomerase I inhibitors via cooperative modulation of hypoxia-inducible factor-1α.
Cai TY; Liu XW; Zhu H; Cao J; Zhang J; Ding L; Lou JS; He QJ; Yang B
Mol Cancer Ther; 2014 Mar; 13(3):630-42. PubMed ID: 24362462
[TBL] [Abstract][Full Text] [Related]
20. Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: their preparation, release behavior, and therapeutic efficiency against colonic cancer.
Lu B; Zhang Z
J Pharm Sci; 2006 Dec; 95(12):2619-30. PubMed ID: 16917869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
